Hyloris' Post-Op Pain Treatment Maxigesic IV Stalled by CRL from FDA

Hyloris' Post-Op Pain Treatment Maxigesic IV Stalled by CRL from FDA

Submitted by admin on July 4, 2022 - 11:54pm
Source: 
BioSpace
News Tags: 
Hyloris Pharmaceuticals
FDA
Maxigesic IV
post-operative pain
Headline: 
Hyloris' Post-Op Pain Treatment Maxigesic IV Stalled by CRL from FDA
snippet: 

Hyloris Pharmaceuticals has received a complete response letter from the U.S. Food and Drug Administration, seeking clarification on one topic related to its registration of Maxigesic IV.

Do Not Allow Advertisers to Use My Personal information